Beskrywing

The global in vitro diagnostics market in terms of revenue is set to grow by US$ 27 miljard tydens 2021-2027, groei teen 'n saamgestelde jaarlikse groeikoers (CAGR) van 5.4% gedurende die voorspellingsperiode, volgens die data- en ontledingsmaatskappy StrategyHelix. Growth in the geriatric population, increasing prevalence of chronic and infectious diseases, rising demand for in-vitro diagnostics during COVID-19 pandemic are the key factors driving market growth.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2017-2020 en voorspel tot 2027 covering key market aspects like sales value for in vitro diagnostics. The global in vitro diagnostics market is segmented on the basis of product, technique, aansoek, streek, and end user. Per produk, it is categorized into instruments, reagents, and software & services. The reagents segment held the largest market share in 2020. By technique, the in vitro diagnostics market is divided into immunodiagnostics, poc testing, molecular diagnostics, hematology, tissue diagnostics, and clinical chemistry. In 2020, the immunodiagnostics segment held the largest share of the market, and the molecular diagnostics segment is anticipated to register the highest CAGR during 2021 aan 2027. Gebaseer op toepassing, the in vitro diagnostics market is divided into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, en ander. In vitro diagnostics market by region is divided into North America, Asiatiese Stille-Oseaan, Europa, en Res van die Wêreld (RY).

The report has profiled some of the key players of the market such as Abbott Laboratories, Alere Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Ortho-Clinical Diagnostics Inc. (Carlyle Group), Panasonic Healthcare Holdings Co. Bpk. (Bayer AG), QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen Group.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the in vitro diagnostics market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Produk: instruments, reagents, and software & services
Technique: immunodiagnostics, poc testing, molecular diagnostics, hematology, tissue diagnostics, and clinical chemistry
Toepassing: infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, en ander
Eindgebruiker: hospitale, laboratories, homecare, en ander
Streek: Noord-Amerika, Asiatiese Stille-Oseaan, Europa, en Res van die Wêreld (RY)
Jare oorweeg: hierdie verslag dek die tydperk 2017 aan 2027

Sleutelvoordele vir belanghebbendes

Get a comprehensive picture of the global in vitro diagnostics market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Bepaal groeisektore en -neigings vir belegging
Understand what the future of the global in vitro diagnostics market looks like
Identifiseer die mededingende landskap en geleentheidsvenster

INHOUDSOPGAWE

1. Markdefinisie
2. Navorsingsmetodologie
3. Markdata & Outlook
3.1 Markwaarde
3.2 Markwaarde Voorspelling
4. In Vitro Diagnostics Market by Product
4.1 Instrumente
4.2 Reagents
4.3 Software & Dienste
5. In Vitro Diagnostics Market by Technique
5.1 Immunodiagnostics
5.2 Poc Testing
5.3 Molecular Diagnostics
5.4 Hematology
5.5 Tissue Diagnostics
5.6 Clinical Chemistry
6. In Vitro Diagnostics Market by Application
6.1 Infectious Diseases
6.2 Cancer
6.3 Cardiac Diseases
6.4 Immune System Disorders
6.5 Nephrological Diseases
6.6 Gastrointestinal Diseases
6.7 Ander
7. In Vitro Diagnostics Market by Region
7.1 Noord-Amerika
7.2 Asiatiese Stille-Oseaan
7.3 Europa
7.4 Res Van Die Wêreld (Ry)
8. In Vitro Diagnostics Market by End User
8.1 Hospitale
8.2 Laboratories
8.3 Homecare
8.4 Ander
9. Maatskappy profiele
9.1 Abbott Laboratories
9.2 Alere Inc.
9.3 Beckman Coulter Inc. (Danaher Corporation)
9.4 Becton, Dickinson and Company
9.5 Biomerieux SA
9.6 Bio-Rad Laboratories, Inc.
9.7 F. Hoffmann-La Roche Ltd
9.8 Ortho-Clinical Diagnostics, Inc. (Carlyle Group)
9.9 Panasonic Healthcare Holdings Co., Bpk. (Bayer AG)
9.10 QIAGEN N.V.
9.11 Siemens Healthineers AG
9.12 Sysmex Corporation
9.13 Thermo Fisher Scientific Inc.
9.14 Werfen Group
10. Bylaag
10.1 Oor StrategyHelix
10.2 Vrywaring